2SEVENTY BIO, INC.

Profile

Company Names

2SEVENTY BIO, INC.

Addresses

60 BINNEY STREET, CAMBRIDGE, MA 02142

Phone Numbers

339-499-9300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$170,000,009.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-03-17 
$170,000,009.00 
$170,000,009.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
D. 
BAIRD 
EXECUTIVE OFFICER
2SEVENTY BIO, INC.   |  AXCELLA HEALTH INC.
SARAH 
JS 
GLICKMAN 
DIRECTOR
2SEVENTY BIO, INC.
PHILIP 
 
GREGORY 
EXECUTIVE OFFICER
2SEVENTY BIO, INC.
NICOLA 
 
HEFFRON 
EXECUTIVE OFFICER
2SEVENTY BIO, INC.
RAMY 
 
IBRAHIM 
DIRECTOR
BLUEBIRD BIO, INC.   |  2SEVENTY BIO, INC.
NICK 
 
LESCHLY 
EXECUTIVE OFFICER, DIRECTOR
GENETIX PHARMACEUTICALS INC   |  BLUEBIRD BIO, INC.   |  PROCLARA BIOSCIENCES, INC.   |  SYNLOGIC, INC.   |  SYNLOGIC, INC.   |  2SEVENTY BIO, INC.   |  EDISON SCIENTIFIC, INC.
DANIEL 
 
LYNCH 
DIRECTOR
AVILA THERAPEUTICS INC   |  STROMEDIX INC   |  BLUEPRINT MEDICINES CORP   |  RANA THERAPEUTICS, LLC   |  PROCLARA BIOSCIENCES, INC.   |  RANA THERAPEUTICS, INC.   |  SPRINGWORKS THERAPEUTICS, LLC   |  XILIO THERAPEUTICS, INC.   |  2SEVENTY BIO, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  GU CAPITAL LP
MARCELA 
V. 
MAUS 
DIRECTOR
2SEVENTY BIO, INC.
WILLIAM 
R. 
SELLERS 
DIRECTOR
BLUEBIRD BIO, INC.   |  2SEVENTY BIO, INC.
DENICE 
 
TORRES 
DIRECTOR
WYLEI, INC.   |  BLUEBIRD BIO, INC.   |  2SEVENTY BIO, INC.   |  SEAPORT THERAPEUTICS, INC.   |  BYHEART, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-03-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GOLDMAN SACHS + CO. LLC
361